anti-ASS1 (ASS1) Antikörper

anti-Argininosuccinate Synthase 1 Antikörper (ASS1)
Auf finden Sie aktuell 105 Argininosuccinate Synthase 1 (ASS1) Antikörper von 17 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen ASS1 Proteine (20) und ASS1 Kits (16) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 148 ASS1 Produkte verfügbar.
AA408052, Ass, Ass-1, ASSA, CTLN1, fold, wu:fb95a04, wu:fc01e08, zgc:92051

Meistgesuchte Reaktivitäten zu anti-ASS1 (ASS1) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human ASS1 Antikörper:

anti-Rat (Rattus) ASS1 Antikörper:

anti-Mouse (Murine) ASS1 Antikörper:

Alle verfügbaren anti-ASS1 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-ASS1 Antikörper

  1. Human Polyclonal ASS1 Primary Antibody für EIA, IHC (p) - ABIN950542 : Hozyasz, Mostowska, Wojcicki, Lianeri, Jagodzinski: Polymorphic variants of genes related to arginine metabolism and the risk of orofacial clefts. in Archives of oral biology 2010 (PubMed)
    Zeige alle 5 Referenzen für 950542

  2. Cow (Bovine) Polyclonal ASS1 Primary Antibody für IHC (p), IHC - ABIN314255 : Hao, Xie, Gross: Argininosuccinate synthetase is reversibly inactivated by S-nitrosylation in vitro and in vivo. in The Journal of biological chemistry 2004 (PubMed)
    Zeige alle 3 Referenzen für 314255

  3. Human Polyclonal ASS1 Primary Antibody für IP, ELISA - ABIN190834 : Corbin, Pendleton, Solomonson, Eichler: Phosphorylation of argininosuccinate synthase by protein kinase A. in Biochemical and biophysical research communications 2008 (PubMed)
    Zeige alle 2 Referenzen für 190834

  4. Human Monoclonal ASS1 Primary Antibody für ICC, FACS - ABIN969502 : Laróvere, Angaroni, Antonozzi, Bezard, Shimohama, de Kremer: Citrullinemia type I, classical variant. Identification of ASS-p~G390R (c.1168G>A) mutation in families of a limited geographic area of Argentina: a possible population cluster. in Clinical biochemistry 2009 (PubMed)

  5. Human Polyclonal ASS1 Primary Antibody für EIA, WB - ABIN452770 : Engel, Höhne, Häberle: Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene. in Human mutation 2009 (PubMed)

Weitere Antikörper gegen ASS1 Interaktionspartner

Human Argininosuccinate Synthase 1 (ASS1) Interaktionspartner

  1. update reports 137 mutations in the ASS1 gene (64 of which are novel), consisting of 89 missense mutations, 19 nonsense mutations, 17 mutations that affect splicing, and 12 deletions; the change p.Gly390Arg is by far the most common mutation and is widely spread throughout the world

  2. Of 21 ASS potential kinetic mutations, 13 were totally inactive while 8 exhibited decreased affinity for aspartate and citrulline.

  3. Low ASS1 expression was associated with higher recurrence , shorter disease-free survival and shorter overall survival in patients with pancreatic ductal adenocarcinoma.

  4. The authors showed that ASS1 mutations linked to type I citrullinemia disrupt the ASS1-PRMT7 (zeige PRMT7 Antikörper) interaction, which might explain the molecular pathogenesis of the disease.

  5. Identification of three novel CTLN1 mutations in fourteen patients with citrullinemia type 1 has been reported.

  6. In this trial, arginine deprivation with ADI-PEG20 improved PFS in patients with ASS1-deficient mesothelioma. Targeting arginine is safe and warrants further clinical investigation in arginine-dependent cancers.

  7. combining hypoxia and ADI-PEG20 synergistically inhibited ASS1.

  8. ASS1 genomic variants (rs10901080 and rs10793902) can serve as pharmacogenomic biomarkers to predict hydroxyurea treatment efficacy in sickle cell disease/beta-thalassemia compound heterozygous patients.

  9. results show that ASS1 is elevated at the mRNA and protein levels in mesothelioma 3D spheroids and in human pleural mesotheliomas. We also have uncovered a survival role for ASS1

  10. results demonstrate that ASS1 downregulation is a novel mechanism supporting cancerous proliferation, and they provide a metabolic link between the urea cycle enzymes and pyrimidine synthesis

Cow (Bovine) Argininosuccinate Synthase 1 (ASS1) Interaktionspartner

  1. calcium-dependent phosphorylation of argininosuccinate synthase Ser (zeige SIGLEC1 Antikörper)-328 is mediated by PKCalpha (zeige PKCa Antikörper)

  2. dose-dependent reduction of ASS as a result of siRNA treatment corresponded to diminished capacity to produce NO, despite saturating levels of arginine in the medium; reduced expression of ASS resulted in loss of viability due to apoptosis

  3. In endothelial cells TNF-alpha (zeige TNF Antikörper) coordinately downregulates nitric oxide synthase (zeige NOS Antikörper) (eNOS (zeige NOS3 Antikörper)) and argininosuccinate synthase expression, resulting in a severely impaired citrulline-NO cycle.

  4. These results represent the first demonstration that vascular endothelial nitric oxide production can be regulated by dynamic argininosuccinate synthase phosphorylation.

Mouse (Murine) Argininosuccinate Synthase 1 (ASS1) Interaktionspartner

  1. In diabetic mice, ablation of Ass resulted in diminished endothelium-derived nitric oxide-mediated vascular relaxation responses.

  2. cAMP-induced Ass1 expression is important in controlling the magnitude of decidualization through regulating L-Arg level.

  3. We demonstrate that the transgenic mouse system reported here has the merit of sensitivity and direct visualization advantage, and is ideal for annotating temporal and spatial expression profiles and the regulation mode of the ASS gene.

  4. Thus, extracellular arginine fuels rapid NO production in activated macrophages, and citrulline recycling via Ass1 and Asl (zeige ADSL Antikörper) is a fail-safe system that sustains optimum NO production.

  5. Partial argininosuccinate synthase ablation protects only in acute ethanol-induced liver injury by decreasing nitrosative stress but not in a more chronic scenario where oxidative stress and impaired fatty acid beta-oxidation are key events.

  6. Loss of Ass1 is associated with citrullinemia type I and other hyperammonemic syndromes.

ASS1 Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of this gene cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene.

Alternative names and synonyms associated with ASS1

  • argininosuccinate synthase 1 (ASS1) Antikörper
  • argininosuccinate synthetase 1 (ass1) Antikörper
  • argininosuccinate synthase 1 (ass1) Antikörper
  • argininosuccinate synthase 1 (Ass1) Antikörper
  • argininosuccinate synthetase 1 (Ass1) Antikörper
  • AA408052 Antikörper
  • Ass Antikörper
  • Ass-1 Antikörper
  • ASSA Antikörper
  • CTLN1 Antikörper
  • fold Antikörper
  • wu:fb95a04 Antikörper
  • wu:fc01e08 Antikörper
  • zgc:92051 Antikörper

Bezeichner auf Proteinebene für ASS1

argininosuccinate synthetase 1 , argininosuccinate synthase , citrulline--aspartate ligase , arginosuccinate synthetase , argininosuccinate synthase 1 , argininosuccinate synthase-like , citrulline-aspartate ligase , citrullinemia , arginosuccinate synthetase 1

414411 Sus scrofa
447864 Danio rerio
496645 Xenopus (Silurana) tropicalis
100218639 Taeniopygia guttata
100396479 Callithrix jacchus
100465731 Ailuropoda melanoleuca
100602356 Nomascus leucogenys
445 Homo sapiens
480693 Canis lupus familiaris
280726 Bos taurus
25698 Rattus norvegicus
417185 Gallus gallus
380488 Xenopus laevis
11898 Mus musculus
Ausgewählte Anbieter für anti-ASS1 (ASS1) Antikörper
Haben Sie etwas anderes gesucht?